Health Promoters and Pharmacists in Diabetes Team Management
NCT ID: NCT01498159
Last Updated: 2018-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
244 participants
INTERVENTIONAL
2011-12-31
2018-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pharmacist-led Group Medical Visits to Help With Diabetes Management
NCT00554671
A Pharmacist-Coordinated Implementation of the Diabetes Prevention Program
NCT02384109
Computer-assisted Diabetes Self-management Interventions
NCT00006163
Peer-led and Telehealth Comparative Effectiveness Research (CER) Adoption for Diabetes Prevention and Management
NCT01307137
Improving Diabetes Care Collaboratively in the Community
NCT00359996
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pharmacist + Health Promoter
Participants in this group will receive support from both a pharmacist and health promoter. Number of sessions will be determined by the study team member and patient.
Pharmacist disease/medication management
Pharmacist-patient encounters
Pharmacist medication intensification and adherence support
Pharmacist communication with primary care physicians
Pharmacist documentation in electronic medical record
Health promoter-patient encounters in-person or by phone
Health promoter medication and lifestyle support
Health promoter communication with pharmacists
Pharmacist
Participants will receive support from pharmacist.
Pharmacist disease/medication management
Pharmacist-patient encounters
Pharmacist medication intensification and adherence support
Pharmacist communication with primary care physicians
Pharmacist documentation in electronic medical record
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pharmacist disease/medication management
Pharmacist-patient encounters
Pharmacist medication intensification and adherence support
Pharmacist communication with primary care physicians
Pharmacist documentation in electronic medical record
Health promoter-patient encounters in-person or by phone
Health promoter medication and lifestyle support
Health promoter communication with pharmacists
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Verbal fluency in English or Spanish
* Age 21 or above
* History of type 2 diabetes (\> 1 year)
* Hemoglobin A1c ≥ 8.0% (within 1 year)
* Receives primary care at UIMC (\> 1 year)
* Taking at least one oral medication for diabetes or hypertension
Exclusion Criteria
* Lives outside Chicago communities of recruitment (3+ months/year)
* Household member already participating in same study
* Plans to move from the Chicago area within the next year
* Pregnant or trying to get pregnancy
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
University of Illinois at Chicago
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ben Gerber
Professor of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ben S Gerber, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Illinois at Chicago
Lisa K Sharp, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Illinois at Chicago
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Illinois Medical Center
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gerber BS, Cano AI, Caceres ML, Smith DE, Wilken LA, Michaud JB, Ruggiero LA, Sharp LK. A pharmacist and health promoter team to improve medication adherence among Latinos with diabetes. Ann Pharmacother. 2010 Jan;44(1):70-9. doi: 10.1345/aph.1M389. Epub 2009 Dec 22.
Gerber BS, Rapacki L, Castillo A, Tilton J, Touchette DR, Mihailescu D, Berbaum ML, Sharp LK. Design of a trial to evaluate the impact of clinical pharmacists and community health promoters working with African-Americans and Latinos with diabetes. BMC Public Health. 2012 Oct 23;12:891. doi: 10.1186/1471-2458-12-891.
Sharp LK, Tilton JJ, Touchette DR, Xia Y, Mihailescu D, Berbaum ML, Gerber BS. Community Health Workers Supporting Clinical Pharmacists in Diabetes Management: A Randomized Controlled Trial. Pharmacotherapy. 2018 Jan;38(1):58-68. doi: 10.1002/phar.2058. Epub 2017 Nov 30.
Nabulsi NA, Yan CH, Tilton JJ, Gerber BS, Sharp LK. Clinical pharmacists in diabetes management: What do minority patients with uncontrolled diabetes have to say? J Am Pharm Assoc (2003). 2020 Sep-Oct;60(5):708-715. doi: 10.1016/j.japh.2020.01.024. Epub 2020 Feb 27.
Locatelli SM, Sharp LK, Syed ST, Bhansari S, Gerber BS. Measuring Health-related Transportation Barriers in Urban Settings. J Appl Meas. 2017;18(2):178-193.
Related Links
Access external resources that provide additional context or updates about the study.
IHRP Study Description
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-0099
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.